Hampton University
The Hampton University Proton Therapy Institute Continues to Treat Cancer through Advocacy, Education and State-of-the-Art Medicine
01/22/2020 - #157

“Of all the forms of inequality, injustice in health is the most shocking and most inhuman because it often results in physical death.” – Dr. Martin Luther King, Jr.

HAMPTON, Va. (January 22, 2020) – According to the latest reports from the American Cancer Society, the rate of deaths caused by cancer in the United States is decreasing. Since its inception in 2010, the Hampton University Proton Therapy Institute (HUPTI) has dramatically contributed to that reduction. HUPTI has served cancer patients in over 318 cities, towns, and counties in the Commonwealth of Virginia.

 “The Hampton University Proton Therapy Institute is a special place. It is a patient treatment facility for people with cancer. It is also a research and academic institution that builds upon Hampton’s legacy of knowledge. More importantly, HUPTI is producing scientific discoveries and innovation,” said Hampton University President, Dr. William R. Harvey. “Our Institute demands the pursuit of excellence by achieving results that are actually easing human misery and saving lives.”

Through advocacy, education and state-of-the-art precision medicine, HUPTI has been treating breast, lung, prostate, head and neck, ocular, GI, brain and spine and pediatric cancers since Dr. Harvey had the vision over 10 years ago to start what would become the largest free-standing proton therapy facility in the world.

Cancer remains the leading cause of death in Virginia, and even though HUPTI has helped contribute to the reduction of cancer, this disease is still plaguing the African-American community. According to the American Cancer Society, “Blacks have the highest death rate and shortest survival of any racial/ethnic group in the US for most cancers.” They also stated, “Black men have the highest cancer incidence rate.”

In a patient analysis conducted by HUPTI, 23% of HUPTI patients from inception of the Institute through September 2018 were African-American male. In the same analysis, 60% of patients at HUPTI were diagnosed with prostate cancer, followed by brain, and head and neck cancer. According to the American Cancer Society’s 2019 report, prostate cancer is the most common cancer among males (20%), followed by lung and colorectal cancers. In addition, the highest incidence rates of cancer occur in black males.

The Hampton University Proton Therapy Institute offers proton therapy, precise and effective treatment in a noninvasive, pain free environment. Proton therapy often results in fewer side effects and less damage to surrounding tissue and organs as compared to traditional cancer treatments. HUPTI is committed to delivering the latest precision medicine advances in cancer-fighting technologies and research, as well as a continued focus on excellence in patient care.

For more information about HUPTI, please visit http://www.hamptonproton.org/ or call Cordereau Dye at 757-251-6814.



©2020 Hampton University
Hampton, VA 23668 : 757.727.5000